Rahman Md Ashrafur, Victoros Evangelos, Shanjana Yeasna, Thomas Marie Roke, Islam Md Rabiul
Nesbitt School of Pharmacy Wilkes University Wilkes-Barre Pennsylvania USA.
Department of Environmental Sciences North South University Bashundhara Dhaka Bangladesh.
Health Sci Rep. 2024 Oct 29;7(11):e70160. doi: 10.1002/hsr2.70160. eCollection 2024 Nov.
Inconsequential diseases can sometimes become extremely dangerous through mutation. Antifungal resistance has increased by 24%, and resistance only due to () species have increased by 60%. Here, we aimed to assess the knowledge of antifungal treatment and preventative measures to mitigate the consequences of infections caused by .
We performed a comprehensive literature search and gathered information for this review from publicly available published articles. We used , infection, mycoses, and antifungal resistance as search terms in Google Scholar, PubMed, and Scopus. We extracted the relevant information from the available article after careful evaluation.
The genus was especially difficult to diagnose, as it was often mistaken for other types of yeast and led to incorrect treatment. The only effective method for diagnosing is through blood culture testing in laboratories and PCR tests. Because of its mutation, has grown increasingly resistant to all three classes of antifungals, with almost all strains resistant to fluconazole. These resistances were traced back to multiple-point mutations in certain genes, such as ERG11 in the case of fluconazole and amphotericin B. In addition, phylogenetically related to , an emerging pathogen notably resistant to antifungals. So, it may be an evolutionary resistance that occurred earlier but has only begun to spread now. Echinoderm, a reliable treatment for infections showed ineffectively against FKS1 and ERG3 gene mutated strains. Newly developed antifungal agents, like Ibrexafungerp, showed promising results against echinocandin-resistant strains in clinical trials.
Without vaccines and effective treatment, its capacity to mutate and spread has detrimental effects on humans. Therefore, extensive research on drug development, quick, reliable diagnosis, and effective strategies for disease prevention and treatment are required to mitigate the health impact of .
一些原本无关紧要的疾病有时会因突变而变得极其危险。抗真菌耐药性增加了24%,仅由()种导致的耐药性就增加了60%。在此,我们旨在评估抗真菌治疗知识以及预防措施,以减轻由()引起的感染后果。
我们进行了全面的文献检索,并从公开的已发表文章中收集了本综述的信息。我们在谷歌学术、PubMed和Scopus中使用()、感染、真菌病和抗真菌耐药性作为检索词。经过仔细评估后,我们从现有文章中提取了相关信息。
()属特别难以诊断,因为它经常被误诊为其他类型的酵母,从而导致治疗错误。诊断()的唯一有效方法是通过实验室血培养检测和PCR检测。由于其突变,()对所有三类抗真菌药物的耐药性都在增加,几乎所有菌株都对氟康唑耐药。这些耐药性可追溯到某些基因的多点突变,例如氟康唑和两性霉素B情况下的ERG11。此外,()与()在系统发育上相关,()是一种对抗真菌药物具有显著耐药性的新兴病原体。所以,这可能是一种较早出现但直到现在才开始传播的进化耐药性。棘白菌素是治疗()感染的可靠药物,但对FKS1和ERG3基因突变的()菌株无效。新开发的抗真菌药物,如ibrexafungerp,在临床试验中对棘白菌素耐药菌株显示出有希望的结果。
由于没有疫苗和有效的治疗方法,其突变和传播能力对人类有不利影响。因此,需要对药物开发、快速可靠的诊断以及疾病预防和治疗的有效策略进行广泛研究,以减轻()对健康的影响。